Contraceptive Technology Update – August 1, 2003
August 1, 2003
View Issues
-
Hormone therapy offers no benefit on central nervous system outcomes
Expect more questions from patients about hormone therapy (HT) with the publication of three reports from the Womens Health Initiative (WHI), the largest randomized controlled trial conducted to date on the drug therapy. -
Research eyes EC regimens, timing issues
What is your clinics protocol when it comes to emergency contraception (EC)? New research indicates that because the Yuzpe EC regimen of combined oral contraceptives (OCs) is at least partially effective when started up to 120 hours after unprotected intercourse, current protocols may be too restrictive.1 -
New vasectomy clip receives FDA approval
The Food and Drug Administration (FDA) has approved a new device to be used in vasectomy procedures: the Vasclip, a small polymeric clip designed to stop the flow of sperm through the vas deferens. -
1 in 5 teens has sex before 15th birthday
A 13-year-old female sits in your exam room. On her initial gynecologic exam at age 12, she did not indicate that she was sexually active. -
You can close the gap on unplanned pregnancies
How did this happen? asks the woman sitting in your office as you share the news from the pregnancy test. I was using birth control. -
New AIDS law contains anti-condom provisions
At the end of May, President Bush signed into law the United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act, which is sweeping legislation designed to provide relief for HIV/AIDS in Africa and the Caribbean and authorizing funding of up to $15 billion over five years. -
Contraceptive Technology Reports: Examination of Extended Hormonal Contraception to Reduce Bleeding
Frequent menstruation is a relatively new biologic state that has emerged as societies have evolved from hunting and gathering to industrialization. -
STD Quarterly: The war gears up against HIV: Scientists and providers seek enhanced prevention
When it comes to the battle against HIV, its time to redouble your efforts at reducing the number of new HIV infections. Why? Reports show an increase of newly diagnosed infections during 1999-2001, which reverses a several-year decline. -
STD Quarterly: Group issues guidelines on chlamydia screening
The push for chlamydia screening has been intensified, with the Washington, DC-based American College of Preventive Medicine (ACPM) issuing a practice policy statement calling for the annual screening of all sexually active women 25 years of age or younger, as well as sexually active women with other risk factors.